Lilly offers investors safety and growth.

SpaceX recently completed a record IPO.

Eli Lilly holds a dominant market share in the weight loss treatment category.

The GLP-1 drug market is massive and still growing fast. Investing in a promising growth stock in the space could lead to ...

Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43. We rate LLY a buy with a 90% confidence score.

There are some good reasons why investors might want to avoid Eli Lilly (NYSE: LLY). For example, its price-to-earnings ratio is high at 40x, and its yield is very low at just 0.6%. But there are also ...

ProQR Therapeutics has priced a registered direct offering of 27.6M ordinary shares at $1.81 per share, expecting to raise about $50M in gross proceeds before expenses. Separately ...

Most of the U.S. stock market rose Friday after oil prices eased back to where they were before the war with Iran, ...

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...